|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 25 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$57,082 |
I/I |
3,514 |
80,733 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-17 |
4 |
S |
$14.80 |
$52,318 |
I/I |
(3,535) |
49,128 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$30,642 |
I/I |
3,536 |
5,006,172 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-10 |
4 |
B |
$4.03 |
$14,503 |
I/I |
3,597 |
4,005,919 |
2.17 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-02-24 |
4 |
B |
$3.35 |
$12,224 |
I/I |
3,649 |
6,532 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-08 |
4 |
B |
$5.92 |
$21,734 |
I/I |
3,669 |
166,824 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-05-20 |
4 |
B |
$9.72 |
$36,061 |
I/I |
3,710 |
481,092 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-16 |
4 |
B |
$5.80 |
$21,912 |
I/I |
3,776 |
141,463 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-09-08 |
4 |
B |
$14.82 |
$56,337 |
I/I |
3,801 |
4,933,530 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
S |
$7.38 |
$28,112 |
I/I |
(3,811) |
1,393,177 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
B |
$7.30 |
$27,820 |
I/I |
3,811 |
1,396,988 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-23 |
4 |
S |
$14.86 |
$56,768 |
I/I |
(3,820) |
159,739 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2011-12-07 |
4 |
B |
$13.21 |
$51,256 |
I/I |
3,878 |
330,387 |
2.25 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$16,109 |
I/I |
(3,880) |
125,534 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-21 |
4 |
B |
$5.90 |
$23,653 |
I/I |
3,913 |
225,216 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$31,668 |
I/I |
3,922 |
152,985 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-05 |
4 |
S |
$12.05 |
$47,439 |
I/I |
(3,936) |
630,898 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-15 |
4 |
B |
$28.88 |
$113,892 |
I/I |
3,944 |
1,384,149 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-09-02 |
4 |
B |
$14.54 |
$57,699 |
I/I |
3,969 |
4,929,729 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-12-19 |
4 |
B |
$11.14 |
$44,449 |
I/I |
3,990 |
95,646 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-12-19 |
4/A |
B |
$11.14 |
$44,449 |
I/I |
3,990 |
99,636 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-13 |
4 |
S |
$12.02 |
$48,050 |
I/I |
(3,997) |
566,588 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-11 |
4 |
B |
$27.66 |
$112,088 |
I/I |
4,052 |
179,045 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-28 |
4 |
B |
$1.82 |
$7,691 |
I/I |
4,056 |
159,011 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-07 |
4 |
S |
$12.25 |
$49,742 |
I/I |
(4,059) |
498,621 |
0 |
- |
|
1397 Records found
|
|
Page 25 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|